Rayence's latest marketcap:
As of 08/14/2025, Rayence's market capitalization has reached $70.59 M. According to our data, Rayence is the 27576th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 70.59 M |
| Revenue (ttm) | 84.58 M |
| Net Income (ttm) | 2.67 M |
| Shares Out | 15.74 M |
| EPS (ttm) | 0.17 |
| Forward PE | 12.36 |
| Ex-Dividend Date | 12/27/2024 |
| Earnings Date | 08/12/2025 |
Rayence's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/14/2025 | ₩97.72 B | $70.59 M | 4.23% | 27576 |
| 12/30/2024 | ₩96.78 B | $64.84 M | -34.22% | 26166 |
| 12/28/2023 | ₩147.14 B | $113.29 M | -15% | 22238 |
| 12/29/2022 | ₩173.1 B | $136.75 M | -10.2% | 20312 |
| 12/30/2021 | ₩192.77 B | $161.93 M | 11.87% | 20096 |
| 12/30/2020 | ₩172.31 B | $158.53 M | -17.36% | 18003 |
| 12/30/2019 | ₩208.51 B | $179.32 M | -20.48% | 15292 |
| 12/28/2018 | ₩262.19 B | $233.35 M | -11.62% | 13180 |
| 12/28/2017 | ₩296.67 B | $275.9 M | 4.26% | 13236 |
| 12/29/2016 | ₩284.54 B | $233.32 M | 12178 |
Company Profile
About Rayence Co., Ltd.
Rayence Co., Ltd., along with its subsidiaries, specializes in the development, manufacturing, and sale of digital X-ray detector products. The company serves various sectors, including dental, medical, veterinary, and industrial markets, with operations in South Korea, the United States, Mexico, China, and internationally.
Product Offerings
- TFT/CMOS X-ray Detectors: Designed for general radiography, C-arm/RF, mammography, and radiotherapy.
- CMOS/Super IGZO TFT/a-Si TFT X-ray Detectors: Used in dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, and more.
- Radiography Imaging Software: Includes Xmaru Pro, Xmaru View V1, Xmaru W, Xmaru RF, Xmaru NDT, Vetview Pro, VXV console, Ez Dent Vet, Xmaru PACS, and VXV PACS.
- Medical Information Systems: Tailored for veterinary hospitals.
- Veterinary Services: Engages in wholesale and retail of veterinary medical devices and drugs.
Research & Development
Rayence is actively involved in R&D for process facilities and deposition materials, ensuring cutting-edge technology in its product lines.
Company Background
Founded in 2011, Rayence Co., Ltd. is headquartered in Hwaseong-si, South Korea.
Frequently Asked Questions
-
What is Rayence's (KOSDAQ-228850) current market cap?As of 08/14/2025, Rayence (including the parent company, if applicable) has an estimated market capitalization of $70.59 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Rayence (KOSDAQ-228850) rank globally by market cap?Rayence global market capitalization ranking is approximately 27576 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.